More about
Intermediate And High-Risk Myelofibrosis
News
December 21, 2023
3 min watch
Save
VIDEO: Ruxolitinib plus pelabresib shows promise in MANIFEST-2 study
In this video, John Mascarenhas, MD, discussed the MANIFEST-2 study into combination therapies in myelofibrosis treatment, which was presented at the ASH Annual Meeting and Exposition.